Cart
sales@molnova.com
Laromustine
CAS No. 173424-77-6
Laromustine( —— )
Catalog No. M36332 CAS No. 173424-77-6
Laromustine (VNP40101M) is a sulfonyl hydrolytic alkylating prodrug used in cancer therapy with significant anticancer activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 686 | In Stock |
|
| 10MG | 938 | In Stock |
|
| 25MG | 1444 | In Stock |
|
| 50MG | 1841 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLaromustine
-
NoteResearch use only, not for human use.
-
Brief DescriptionLaromustine (VNP40101M) is a sulfonyl hydrolytic alkylating prodrug used in cancer therapy with significant anticancer activity.
-
DescriptionLaromustine (VNP40101M) is a sulfonyl hydrolytic alkylating prodrug used in cancer therapy with significant anticancer activity. Inhibiting thioredoxin reductase can be used to study acute myeloid leukemia.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
RecptorDNA/RNA Synthesis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number173424-77-6
-
Formula Weight307.78
-
Molecular FormulaC6H14ClN3O5S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NC)N(N(CCCl)S(=O)(=O)C)S(=O)(=O)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
SMN-C3
SMN-C3 (MV8T2MCK57) is an orally active modulator of SMN2 splicing, and has the potential to treat spinal muscular atrophy (SMA).
-
Ddr1-In-1
DDR1-IN-1 is an effective and specific?DDR1?receptor tyrosine kinase inhibitor (IC50: 105 nM), about 3-fold selectivity over DDR2.
-
UM-164
UM-164 is a highly potent inhibitor of?c-Src?with a?Kd?of 2.7 nM. UM-164 also potently inhibits?p38α?and?p38β.
